What Is a Certificate of Analysis (COA)? Why It Matters When Sourcing Research Peptides in Canada

When sourcing research-grade peptides for laboratory use, the Certificate of Analysis (COA) is the single most important document a researcher can request. It is the primary evidence of a compound's identity, purity, and quality — and yet it is one of the most misunderstood and underutilized tools available to research buyers in Canada.

This guide is designed for researchers, lab managers, and procurement teams who want to understand what a COA actually contains, how to evaluate its reliability, what makes a third-party COA different from an in-house one, and how to use COA data to make informed sourcing decisions. Understanding the COA is essential for protecting the integrity of your research and ensuring that the materials you use are what they claim to be.

All content is for educational and informational purposes only. All peptides referenced are designated for research use only and are not approved for human or veterinary use.

What Is a Certificate of Analysis?

A Certificate of Analysis (COA) is a formal quality assurance document issued by a testing laboratory that records the results of analytical testing performed on a specific batch or lot of a chemical or biological compound. For research peptides, the COA confirms that the material in a specific vial — from a specific production lot — meets defined quality specifications.

It is essentially the analytical passport of the peptide: evidence that the compound has been tested, that the testing methodology meets professional standards, and that the results are on record and attributable to a specific lot.

A COA is not a general claim about a supplier's product line. It is a lot-specific document tied to a specific production batch. Every time a new batch is produced, a new COA should be generated.

Why a COA Is Essential for Peptide Research

Data Reproducibility

Scientific reproducibility requires confidence that the materials used in an experiment are consistent across batches and time points. If Researcher A achieves results with Lot X of BPC-157 and Researcher B cannot replicate those results with Lot Y, one of the first questions is: were the two lots actually the same compound at the same purity? A COA provides the lot-specific data needed to answer this question.

Research Validity

If the peptide you are working with contains significant impurities — truncated sequences, synthesis by-products, or contaminating compounds — those impurities may be pharmacologically active and influencing your results. A ≥99% purity COA significantly reduces this risk. Absence of purity documentation leaves your results scientifically uncertain.

Institutional and Regulatory Compliance

Many academic and industrial research institutions require COA documentation as part of their material procurement and lab compliance frameworks. IRB/REB-governed research, in particular, may require documentation that research materials meet defined quality specifications.

Supplier Accountability

A supplier who provides independently verified COA documentation for each lot is taking accountability for their product's quality in a way that a supplier who only makes verbal purity claims is not. COA data is a contractual form of quality assurance.

What a Research Peptide COA Should Contain

Not all COAs are equal. Here is what a properly formatted, research-grade peptide COA should include:

1. Product Identification

  • Peptide name (common name and/or IUPAC name)
  • Molecular formula
  • Molecular weight (theoretical and observed)
  • CAS number (if applicable)
  • Lot or batch number

This section confirms what compound was tested. Without this, the COA cannot be tied to the specific product.

2. HPLC Purity Data

High-Performance Liquid Chromatography (HPLC) is the gold-standard method for measuring peptide purity. The COA should report:

  • Purity percentage (e.g., ≥99.0%)
  • Method used (e.g., reverse-phase HPLC with UV detection at 220nm)
  • Chromatogram reference (ideally, the HPLC chromatogram itself or reference to it)

The purity percentage represents the area under the target peptide's HPLC peak as a proportion of all detected peaks — meaning 99% purity indicates the target compound constitutes 99% of the total detectable material.

What adequate looks like: ≥95% for general research use; ≥99% for sensitive assays or analytical standards.

What to watch out for: Unspecified or vague purity statements without an analytical method. "99% pure" is meaningless without knowing how that was measured.

3. Mass Spectrometry (MS) Data

Mass spectrometry confirms molecular identity by measuring the mass-to-charge ratio (m/z) of the peptide and comparing it to the theoretical molecular weight.

The COA should show:

  • Observed molecular weight from MS analysis
  • Expected (theoretical) molecular weight
  • Agreement — typically expressed as [M+H]+ or [M+2H]2+ ions in ESI-MS data

MS data answers the question "is this the correct molecule?" — complementing HPLC's answer to "how pure is it?" Both are necessary for complete quality confirmation. A peptide can be 99% pure but be the wrong sequence — MS would catch this; HPLC alone would not.

4. Testing Laboratory Information

  • Name and contact information of the testing laboratory
  • Date of testing
  • Analyst or quality manager signature (for formal COAs)

This is the section that distinguishes a third-party COA from an in-house COA — and this distinction is critical.

5. Certificate of Conformance (COC)

Some suppliers provide a Certificate of Conformance alongside or instead of a full COA. A COC confirms that the product meets defined specifications but may not include the raw analytical data. For research use, a full COA with raw HPLC and MS data is preferable to a COC alone.

Third-Party vs. In-House COAs: A Critical Distinction

This is the most important quality distinction researchers need to understand when evaluating peptide suppliers.

In-House COA

An in-house COA is produced by the supplier's own laboratory, testing their own products, using their own equipment and staff. While in-house testing is not inherently fraudulent, it represents an unverified claim: the supplier is essentially saying "we tested it and it meets our standards."

Problems with in-house COAs:

  • No independent verification that the testing was performed correctly
  • No verification that the equipment is calibrated or the method is validated
  • Suppliers can — intentionally or through poor methodology — produce inflated purity numbers
  • There is no accountability to a third party if results are inaccurate

Third-Party COA

A third-party COA is produced by an independent analytical laboratory — a testing facility with no financial relationship to the peptide supplier. The supplier sends samples to this external lab, which tests them using their own equipment, staff, and validated methods, and reports the results independently.

Advantages of third-party COAs:

  • Independent verification — results cannot be manipulated by the supplier
  • Accreditation — reputable third-party labs are often ISO/IEC 17025 accredited, meaning their testing methods meet internationally recognised quality standards
  • Scientific credibility — third-party COA data is citable and auditable
  • Accountability — if results are inaccurate, a third party's professional reputation is at stake

The practical bottom line: When sourcing research peptides, always prefer suppliers who provide third-party COA documentation. In-house COAs, unverified purity claims, or the absence of any COA data are significant red flags.

At Proto Peptide, all compounds — including BPC-157, TB500, the GLOW Blend (GHK-CU+TB500+BPC157), Tesamorelin, Ipamorelin, the KLOW Blend, and our GLP-family compounds — are tested by independent, third-party analytical laboratories. COA documentation is available on request for every product. Visit our FAQ page for more information.

How to Read a Research Peptide COA: A Practical Guide

Receiving a COA is only useful if you know what to look for. Here is a step-by-step reading framework:

Step 1 — Check the lot number. The lot number on the COA should match the lot number printed on your vial. If they do not match, the COA does not document the product you received.

Step 2 — Verify product identity. Confirm the peptide name, molecular formula, and molecular weight match the compound you ordered.

Step 3 — Read the HPLC purity figure. Look for a purity percentage ≥95% for general research use; ≥99% for demanding applications. Note the detection method — UV at 220nm is standard for peptides.

Step 4 — Check the MS data. The observed molecular weight should match the theoretical within normal instrument tolerances (typically ±1–2 Da for MALDI; ±0.01% for high-resolution ESI-MS). Agreement confirms molecular identity.

Step 5 — Identify the testing laboratory. Is it an independent third party, or is it the supplier's own lab? An accredited, independent lab with its name and contact information clearly stated is the gold standard.

Step 6 — Check the date. COA data older than 24 months for a lyophilized peptide may not reflect the current lot's status, particularly if storage conditions since testing are unknown.

Step 7 — Look for additional tests. Some COAs include sterility testing, endotoxin (pyrogen) testing, and TFA content measurements. These are additional quality indicators relevant for cell-based and in vivo research.

Additional Quality Markers Beyond the COA

While the COA is the primary document, additional quality markers are relevant for research applications:

Endotoxin (LAL) Testing

Endotoxins — lipopolysaccharides from Gram-negative bacterial cell walls — are potent immune activators that can confound in vivo and cell culture experiments at very low concentrations. For animal studies or cell-based assays, an endotoxin-tested peptide (European Pharmacopoeia limits: <0.25 EU/mg for injectables) significantly reduces the risk of immune activation confounding your results.

TFA Content

Trifluoroacetic acid (TFA) is commonly used in HPLC purification of synthetic peptides and residual TFA can remain in the final product. TFA can be cytotoxic at higher concentrations in cell culture systems. COAs for cell-biology grade peptides often include TFA content measurement, and some suppliers offer counter-ion exchange to replace TFA with acetate.

Sterility Testing

For in vivo research applications, sterility documentation confirms the absence of microbial contamination. This is distinct from purity — a peptide can be chemically pure but microbiologically contaminated.

Red Flags When Evaluating Peptide Suppliers

Beyond the COA itself, certain supplier behaviours signal quality risk:

  • No COA available, or "available on request" that never arrives. COAs should be readily accessible.
  • COA with no laboratory name or contact information. Cannot be verified.
  • Purity claimed as a round number without analytical data (e.g., "guaranteed 99% pure" without HPLC data). Analytical results are decimal-precise, not marketing round numbers.
  • COA data that is years old for the current lot. Each lot should have current testing data.
  • Unusually low prices — peptide synthesis and quality testing have real costs. Dramatically below-market pricing typically reflects compromises in synthesis quality or testing standards.
  • No lot number on the vial. Without a lot number, the COA cannot be tied to your specific product.

Sourcing COA-Documented Peptides in Canada

For Canadian researchers, sourcing peptides with full third-party COA documentation from a domestic supplier provides the clearest compliance path and eliminates the uncertainty of international sourcing. Proto Peptide provides third-party tested, HPLC-verified peptides with COA documentation available for every product in our catalog.

Our full range includes:

Visit our FAQ page for COA and documentation requests, or browse our full product catalog.

Frequently Asked Questions About Research Peptide COAs

Can I use a COA as proof that a peptide is safe for human use? No. A COA confirms chemical purity and identity — it does not constitute safety data for human use, clinical approval, or regulatory clearance. All Proto Peptide compounds are designated for research use only.

What is the difference between a COA and a COC? A Certificate of Analysis (COA) contains raw analytical data (HPLC chromatograms, MS spectra). A Certificate of Conformance (COC) confirms that a product meets specifications without necessarily providing raw data. A full COA is preferable for research purposes.

How often is a new COA generated? Each production lot requires its own COA. If you receive a new lot, a new COA should be provided for that lot specifically.

Is HPLC purity the same as the peptide being the right compound? No. HPLC measures purity — the proportion of the sample that is the target peptide. Mass spectrometry confirms identity — that the main peak is actually the expected peptide. Both tests together provide complete quality confirmation.

What endotoxin threshold is acceptable for in vivo peptide research? For injectables, the European Pharmacopoeia general limit is <0.25 EU/mg. For CNS research, more stringent thresholds may apply. Consult your institutional protocols for specific requirements.

Conclusion

The Certificate of Analysis is not a bureaucratic formality — it is the scientific and ethical foundation of responsible peptide research. Without COA data, researchers cannot confirm that the compounds they are working with are what they believe them to be, at the concentration and purity required for valid experimental conclusions. Third-party verified COAs raise this assurance to the highest achievable standard by removing supplier self-interest from the testing equation.

For Canadian researchers, Proto Peptide provides third-party tested peptides with full COA documentation — ensuring that every experiment built on our materials starts with verified, documented quality. Explore our full catalog or contact us through our FAQ page for any documentation requests.

This content is intended for informational and educational purposes only. All products are for research use only and are not approved for human or veterinary use. Statements have not been evaluated by the FDA or Health Canada. Always follow your institution's guidelines and consult safety data sheets before handling any research chemical.

Back to blog